Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
05/03/2007 | CA2626565A1 Piperazine derivatives useful as ccr5 antagonists |
05/03/2007 | CA2623898A1 New cyclic peptide compounds |
05/02/2007 | EP1780285A1 Improved virus like particles (VLP) based on the small envelope protein of hepatitis B virus (HBsAg-S) |
05/02/2007 | EP1780214A2 Combinatorial production of nucleotide and nucleoside analogues (XiTP) |
05/02/2007 | EP1780212A1 PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE |
05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
05/02/2007 | EP1779853A2 9a-azalides as veterinary antimicrobial agents |
05/02/2007 | EP1779849A1 V-ATPase inhibitors for the treatment of septic shock |
05/02/2007 | EP1778702A2 Antiviral compounds |
05/02/2007 | EP1778653A1 Biaryl heterocyclic compounds and methods of making and using the same |
05/02/2007 | EP1778361A1 Antimicrobial and/or antiviral composition and to methods for preparing and administering same |
05/02/2007 | EP1778282A1 Mutated hiv nef for modulating immunity |
05/02/2007 | EP1778272A1 Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (hcv) |
05/02/2007 | EP1778271A2 Peptides for the treatment of herpes virus infections |
05/02/2007 | EP1778254A2 Prodrugs activated by rna-dependent dna-polymerases |
05/02/2007 | EP1778251A2 Nucleoside phosphonate conjugates as anti hiv agents |
05/02/2007 | EP1778249A2 Nucleoside phosphonate conjugates as anti hiv agents |
05/02/2007 | EP1778240A2 Dihydropteridinones for the treatment of cancer diseases |
05/02/2007 | EP1539070B1 Antimicrobial, silver-containing wound dressing for continuous release |
05/02/2007 | EP1501521B1 Long acting compositions comprising zidovudine and/or lamivudine |
05/02/2007 | EP1492766B1 Improved cc-1065 analog synthesis |
05/02/2007 | EP1492546B1 Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
05/02/2007 | EP1370256B1 Novel inhibitors of formation of advanced glycation endproducts (ages) |
05/02/2007 | EP1365797B1 Antibodies modulating the upa/upar interaction and uses thereof |
05/02/2007 | EP1345658B1 Methods and vaccines for providing in ovo protection against turkey rhinotracheitis |
05/02/2007 | EP1330467B1 Modified, hydroxy-substituted aromatic structures having cytoprotective activity |
05/02/2007 | EP1144675A4 Pharmacokinetic-based drug design tool and method |
05/02/2007 | EP1100921B1 Streptococcus pneumoniae proteins and nucleic acid molecules |
05/02/2007 | EP1032596B1 Lactalbumin production process |
05/02/2007 | EP1009846B1 Alphavirus-derived vectors useful as vaccines providing protection against paramyxovirus infection |
05/02/2007 | EP0912085B1 Precise efficacy assay methods for active agents including chemotherapeutic agents |
05/02/2007 | CN2894699Y Film-coated tablet of norcantharidin |
05/02/2007 | CN1956992A Anthracycline derivatives |
05/02/2007 | CN1956971A Novel fused heterocycles and application thereof |
05/02/2007 | CN1956961A Stable crystal form of 4-oxoquinoline compound |
05/02/2007 | CN1956732A Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
05/02/2007 | CN1956720A Combination medication for treating HIV infection |
05/02/2007 | CN1956712A Antiviral composition comprising p-menthane-3,8-diol |
05/02/2007 | CN1955305A Method for preparing anthracene Ensamu bacterial |
05/02/2007 | CN1955192A Protein for promoting erythrocyte growth factor activity and its use |
05/02/2007 | CN1955191A New gene PPF1 of class I control infection nail forming efficiency and pathogenicity in flamentous etiological fungus and its use |
05/02/2007 | CN1955190A Polypeptide of controlling IIIv virus fusion and its use |
05/02/2007 | CN1955187A Roxithromycin derivate and its preparation method and medical application |
05/02/2007 | CN1955177A LAM nucleoside derivate, its preparation method and application |
05/02/2007 | CN1954886A Application process of pig interleukin 2 and 6 gene expression plasmid anti-infectious preparation |
05/02/2007 | CN1954885A Preparation and application of compound pig interleukin gene anti-infections nano molecular preparation |
05/02/2007 | CN1954884A Preparation and application of anti-infectious immunity preparation of pig interleukin 6 gene and CpG molecular fusional |
05/02/2007 | CN1954874A Curcuma zedoary oil fat injection and preparation process |
05/02/2007 | CN1954856A Traditional Chinese medicinal compound preparation for treating asthma and its preparation method |
05/02/2007 | CN1954821A Traditional Chinese composite preparation for treating asthma and its preparation method |
05/02/2007 | CN1954818A Application of phillyrin in preparation for treating endotoxemia |
05/02/2007 | CN1954816A Quick-slow compound medicine of anti-tuberculosis |
05/02/2007 | CN1954815A Anti-tuberculosis compound medicine quick-slow double-release preparation and its preparation method |
05/02/2007 | CN1954809A Personal hygiene additive for preventing STD origin of viral and chlamydia |
05/02/2007 | CN1313617C Expression vectors encoding epitopes of target-associated antigens and methods for their design |
05/02/2007 | CN1313605C Gene recombinant fowl influenza virus D3/F-R2/6 and its construction method |
05/02/2007 | CN1313491C Cat omega interferon and its coding gene and uses |
05/02/2007 | CN1313489C GP thymosin alpha 1 and preparation method |
05/02/2007 | CN1313487C Immunoreactive peptide Trpi possessing antibacterial action |
05/02/2007 | CN1313483C Inhibitory peptide of YMDD domain of duck hepatitis-B virus polymerase protein and application thereof |
05/02/2007 | CN1313482C Inhibition peptide of hepatatitis B virus polyzymoprotein YMDD functional region and its application |
05/02/2007 | CN1313472C Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such |
05/02/2007 | CN1313466C 1,3,4 furodiazole carbon-penillien compound, preparation method and application |
05/02/2007 | CN1313459C Total flavone glycoside extract of Radix scutellariae, Rodix scutellariae monomer flavone glycoside, its preparation and use |
05/02/2007 | CN1313152C Vaccines |
05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
05/02/2007 | CN1313145C Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
05/02/2007 | CN1313115C Zoster treating ointment and its prepn |
05/02/2007 | CN1313099C Carbon gas gel transfusion agent, its preparing method and its use |
05/02/2007 | CN1313098C New use of achyranthes polysaccharide sulphate for anti Aids and immune regulation |
05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
05/02/2007 | CN1313081C Valacycloguanosine tablet containing colloid silica |
05/01/2007 | USRE39608 Substituted benzimidazoles and their use as PARP inhibitors |
05/01/2007 | US7211677 3-amino-2-ethoxycarbonylpyrrole; chemical intermediate in synthesis of 3H,5H-pyrrolo[3,2-d]pyrimidin-4-one; a convergent synthesis route rather than a linear one |
05/01/2007 | US7211659 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
05/01/2007 | US7211656 Using the enzymes to make polyunsaturated fatty acids; added to pharmaceutical compositions, nutritional compositions, animal feeds, cosmetics |
05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
05/01/2007 | US7211577 Water-soluble phenylpyridazine derivative and medicine containing the same |
05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
05/01/2007 | US7211572 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor |
05/01/2007 | US7211570 Administering 5-substituted uracil-nucleosides or its pharmaceutically acceptable salt or prodrug for therapy of infected with Epstein-Barr virus or Kaposi's sarcoma-associated herpes ("KHSV") |
05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
05/01/2007 | US7211420 Oxidizing limonene or pinene or a cyclic sesquiterpene, wherein said limonene, pinene or cyclic sesquiterpene is optionally substituted by an alkyl of 1 to 6 carbons or an alkenyl of 1 to 6 carbons with a mutant haem-containing P450 enzyme, wherein mutant enzyme is a mutant of a P450BM-3 |
05/01/2007 | US7211411 Human papilloma virus treatment |
05/01/2007 | US7211404 Liver engrafting cells, assays, and uses thereof |
05/01/2007 | US7211264 Salmonella pathogenicity island two (Spi2) double mutant for use as tool in developing vaccine for treatment and prevention of microorganismal and viral infcetions |
05/01/2007 | US7211260 Infectious bursitis vaccine |
05/01/2007 | CA2452032C Synergistic antimicrobial compositions and methods of inhibiting biofilm formation |
05/01/2007 | CA2340545C Chelate compound-containing antibacterial agent for helicobacter pylori |
05/01/2007 | CA2306963C Novel 3,6-hemiketals from the class of 9a-azalides |
05/01/2007 | CA2191440C Treatment and prevention of helicobacter infection |
05/01/2007 | CA2155493C Carbapenem derivatives containing a bicyclic ketone substituent and their use as anti-infectives |
05/01/2007 | CA2086832C Hepatitis a virus strain, method for the isolation of new hepatitis a virus strains and hepatitis a vaccines |
04/26/2007 | WO2007047405A1 Ddc compositions |
04/26/2007 | WO2007047315A1 Amifostine dihydrate crystalline composition |
04/26/2007 | WO2007046643A1 Composition comprising an extract of pine needle for preventing and treating animal disease caused by viruses and the use thereof |